| __timestamp | Bristol-Myers Squibb Company | Cytokinetics, Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 3932000000 | 44426000 |
| Thursday, January 1, 2015 | 3909000000 | 46398000 |
| Friday, January 1, 2016 | 4946000000 | 59897000 |
| Sunday, January 1, 2017 | 6066000000 | 90296000 |
| Monday, January 1, 2018 | 6547000000 | 89135000 |
| Tuesday, January 1, 2019 | 8078000000 | 86125000 |
| Wednesday, January 1, 2020 | 11773000000 | 96951000 |
| Friday, January 1, 2021 | 9940000000 | 159938000 |
| Saturday, January 1, 2022 | 10137000000 | 240813000 |
| Sunday, January 1, 2023 | 10693000000 | 330123000 |
| Monday, January 1, 2024 | 0 |
Data in motion
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. Bristol-Myers Squibb Company, a titan in the industry, has seen its cost of revenue grow by approximately 172% from 2014 to 2023. This increase reflects strategic investments and scaling operations. In contrast, Cytokinetics, Incorporated, a smaller player, has experienced a staggering 643% rise in the same period, albeit from a much smaller base. This growth underscores its aggressive expansion and innovation efforts.
From 2014 to 2023, Bristol-Myers Squibb's cost of revenue peaked in 2020, coinciding with global health challenges, while Cytokinetics saw its highest costs in 2023, indicating a recent surge in activity. These trends highlight the differing strategies and market positions of these companies, offering insights into their operational priorities and market responses.
AstraZeneca PLC vs Cytokinetics, Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Pfizer Inc. vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Bristol-Myers Squibb Company vs Regeneron Pharmaceuticals, Inc.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Biogen Inc.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Galapagos NV: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down United Therapeutics Corporation and Cytokinetics, Incorporated's Expenses
Cost of Revenue Comparison: Incyte Corporation vs Cytokinetics, Incorporated
Comparing Cost of Revenue Efficiency: Sarepta Therapeutics, Inc. vs Cytokinetics, Incorporated
Cytokinetics, Incorporated vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored